Lucid Diagnostics Aktie News & Nachrichten
[WKN: A3C5EE | Symbol: LUCD]Realtimekurs
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Es konnten keine Nachrichten über Lucid Diagnostics gefunden werden.